Kronox Lab Science Ltd Stock Price Today (NSE: KRONOX)
Fundamental Score
Kronox Lab Science Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Kronox Lab Science Ltd share price today is ₹120.20, up +0.00% on NSE/BSE as of 19 February 2026. Kronox Lab Science Ltd (KRONOX) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹528.25 (Cr). The 52-week high for KRONOX share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 20.47x, KRONOX is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 32.57% and a debt-to-equity ratio of 0.03.
Kronox Lab Science Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Kronox Lab Science Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Kronox Lab Science Share Price: A Financial Analysis Amidst Specialty Chemical Innovation
The specialty chemicals sector is witnessing a surge in demand for customized solutions, pushing companies towards high-margin product development. Assessing the current valuation of *Kronox Lab Science share price* requires a deep dive into its financial health and competitive positioning. The stock currently trades at ₹123.760002, with a PE ratio of 20.47.
One of the most compelling aspects of Kronox Lab Science Ltd is its exceptionally high Return on Capital Employed (ROCE) of 43.82%. This metric suggests strong profitability and efficient capital allocation. A high ROCE effectively widens the company’s economic moat, as it indicates a greater ability to generate profits from investments compared to competitors. This allows for increased reinvestment in research and development, customer acquisition, and potentially, strategic acquisitions, further solidifying its market position.
When evaluating leadership, contrasting Kronox Lab Science with peers is crucial. For instance, comparing Kronox Lab Science Ltd with
Amal and Bhatia Colour regarding management quality, focusing on their track record of innovation and capital deployment, could provide a more nuanced perspective on long-term growth potential. Such comparisons, especially considering Deep Polymers' performance metrics, are an essential part of our analysis.A crucial component of understanding the company's potential, and the impact on Kronox Lab Science share price, is the 43.82% ROCE. As stated before, this allows for strategic re-investment and acquisitions. Companies with high ROCE tend to see an increase in share price as the value of the company becomes more transparent to investors.
This analysis is part of an 80-parameter fundamental audit verified by Sweta Mishra. This analysis is purely observational and does not constitute any investment advice. Please note that this is not a recommendation to buy or sell securities.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kronox Lab Science Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KRONOX across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (32.57%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (43.82%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (27.34%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 20.47 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (14.70% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (24.28% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (869.75x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹59.07 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (74.21%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Weak Earnings Growth (-54.28% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 1.96%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Kronox Lab Science Ltd Financial Statements
Comprehensive financial data for Kronox Lab Science Ltd including income statement, balance sheet and cash flow
About KRONOX (Kronox Lab Science Ltd)
Kronox Lab Science Ltd (KRONOX) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current market capitalisation of ₹528.25 (Cr). Kronox Lab Science Ltd has delivered a Return on Equity (ROE) of 32.57% and a ROCE of 43.82%. The debt-to-equity ratio stands at 0.03, reflecting the company's capital structure. Investors tracking KRONOX share price can monitor key metrics including P/E ratio, promoter holding of 74.21%, and quarterly earnings growth.
Company Details
Key Leadership
KRONOX Share Price: Frequently Asked Questions
What is the current share price of Kronox Lab Science Ltd (KRONOX)?
As of 19 Feb 2026, 10:12 am IST, Kronox Lab Science Ltd share price is ₹120.20. The KRONOX stock has a market capitalisation of ₹528.25 (Cr) on NSE/BSE.
Is KRONOX share price Overvalued or Undervalued?
KRONOX share price is currently trading at a P/E ratio of 20.47x, compared to the industry average of 29.20x. Based on this relative valuation, the Kronox Lab Science Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of KRONOX share price?
The 52-week high of KRONOX share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Kronox Lab Science Ltd share price?
Key factors influencing KRONOX share price include quarterly earnings growth (Sales Growth: 2.70%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Kronox Lab Science Ltd a good stock for long-term investment?
Kronox Lab Science Ltd shows a 5-year Profit Growth of 24.28% and an ROE of 32.57%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.03 before investing in KRONOX shares.
How does Kronox Lab Science Ltd compare with its industry peers?
Kronox Lab Science Ltd competes with major peers in the Specialty Chemicals. Investors should compare KRONOX share price P/E of 20.47x and ROE of 32.57% against the industry averages to determine competitive standing.
What is the P/E ratio of KRONOX and what does it mean?
KRONOX share price has a P/E ratio of 20.47x compared to the industry average of 29.20x. Investors pay ₹20 for every ₹1 of annual earnings.
How is KRONOX performing according to Bull Run's analysis?
KRONOX has a Bull Run fundamental score of 60.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does KRONOX belong to?
KRONOX operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Kronox Lab Science Ltd share price.
What is Return on Equity (ROE) and why is it important for KRONOX?
KRONOX has an ROE of 32.57%, which indicates excellent management efficiency. ROE measures how efficiently Kronox Lab Science Ltd generates profits from shareholders capital.
How is KRONOX debt-to-equity ratio and what does it indicate?
KRONOX has a debt-to-equity ratio of 0.03, which indicates conservative financing with low financial risk.
What is KRONOX dividend yield and is it a good dividend stock?
KRONOX offers a dividend yield of 0.35%, meaning you receive ₹0.35 annual dividend for every ₹100 invested in Kronox Lab Science Ltd shares.
How has KRONOX share price grown over the past 5 years?
KRONOX has achieved 5-year growth rates of: Sales Growth 14.70%, Profit Growth 24.28%, and EPS Growth -54.28%.
What is the promoter holding in KRONOX and why does it matter?
Promoters hold 74.21% of KRONOX shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Kronox Lab Science Ltd.
What is KRONOX market capitalisation category?
KRONOX has a market capitalisation of ₹528 crores, placing it in the Small-cap category.
How volatile is KRONOX stock?
KRONOX has a beta of N/A. A beta > 1 suggests the Kronox Lab Science Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is KRONOX operating profit margin trend?
KRONOX has a 5-year average Operating Profit Margin (OPM) of 27.34%, indicating the company's operational efficiency.
How is KRONOX quarterly performance?
Recent quarterly performance shows Kronox Lab Science Ltd YoY Sales Growth of 2.70% and YoY Profit Growth of 3.25%.
What is the institutional holding pattern in KRONOX?
KRONOX has FII holding of 0.03% and DII holding of 1.93%. Significant institutional holding often suggests professional confidence in the Kronox Lab Science Ltd stock.